Table I. Baseline characteristics of the patients.

Characteristic*	All randomized patients (n = 130)
Mean age (y)	63.6
Male sex, n (%)	106 (82)
Body mass index (kg/m2)	29.7 ± 5.53
Medical history, n (%)
Type II diabetes	39 (30)
Hypertension	95 (73)
CHD	111 (85)
Abdominal aortic aneurysm	5 (4)
>20% Framingham risk	Yes: 39 (30), no: 57 (44), Unknown: 33 (26)
Symptomatic carotid disease	10 (8)
Peripheral arterial disease	16 (12)
Smoking, n (%)
Never	53 (41)
Former	60 (46)
Current	17 (13)
Statin use,† n (%)	113 (87)
Cholesterol (mg/dL)
Total	145.83 ± 27.39
LDL-C	74.18 ± 20.98
HDL-C	44.40 ± 13.52
Triglycerides‡ (mg/dL)	124.5 (88.0-165.0)
CRP (mg/L)	2.98 ± 5.25

CRP indicates C-reactive protein.

^*All reported as mean ± SD, unless otherwise stated.

^†Patients with at least 1 treatment.

^‡Median (interquartile range).